Diagnostic Potential of the NMDA Receptor Peptide Assay for Acute Ischemic Stroke

Abstract

This study suggests that the NR2 peptide may be a brain specific biomarker to diagnose acute IS and may allow the differentiation of IS from stroke mimics and controls. Additional larger scale clinical validation studies are required.